News

Alstom SA (ALSMY) Q3 2025 Earnings Call Transcript

1 Mins read

Alstom SA (OTCPK:ALSMY) Q3 2025 Results Conference Call January 21, 2025 12:30 PM ET

Company Participants

Bernard Delpit – Executive Vice President & Chief Financial Officer

Conference Call Participants

Daniela Costa – Goldman Sachs
Andre Kukhnin – UBS
Akash Gupta – JPMorgan
Gael de-Bray – Deutsche Bank
William Mackie – Kepler Cheuvreux
Martin Wilkie – Citi
Jonathan Mounsey – BNP Paribas Exane

Operator

Hello, and welcome to Alstom’s Nine Months Results for Fiscal Year 2024-2025 Presentation. My name is George, and I’ll be coordinator for today’s events. Please note, this conference is being recorded and for the duration of the call, your lines will be on listen-only. [Operator Instructions] [Operator Instructions]

I’d like to hand you host this evening, Mr. Bernard Delpit, Executive Vice President and Chief Financial Officer. Please go ahead, sir.

Bernard Delpit

Good evening, everyone, and welcome to Alstom’s webcast dedicated to the third quarter of the fiscal year ’24-’25, presenting orders and sales.

Before jumping to slides, let me please emphasize some context points. Market perspectives remain solid, commercial activity is high, and we see a stable pipeline for next quarter, i.e., no change to last talks we had in November with H1 release. A number of large projects have been awarded lately and options on large frame contracts have been exercised. Worth also noting that competition has been intensifying lately in certain regions like Middle East, Asia or Latin America.

That being said, let’s focus on Alstom orders and sales. And I’ll start with orders on Page 3. Order intakes totaled €4.3 billion in Q3, with large orders at €2.2 billion, and a sound level of base orders around €2 billion. So, after nine months, Europe is still leading the pack and represents large maturity of total order intake. 58% of total orders come from services and signaling year-to-date.

Read the full article here

Related posts
News

Recursion Pharmaceuticals, Inc. (RXRX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

1 Mins read
Follow Play Earnings CallPlay Earnings Call Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDT…
News

Nissan Motor: Favorable Read-Across From Latest Investor Event (NSANY)

1 Mins read
This article was written by Follow The Value Pendulum is an Asian equity market specialist with over a decade of experience on…
News

Bilibili: Stock's Risk/Reward Is Completely Different From Last Year (NASDAQ:BILI)

1 Mins read
This article was written by Follow I specialize in fundamental research in the H and A share markets. Analyst’s Disclosure: I/we have…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *